Cryospray ablation (CSA) in the palliative treatment of squamous cell carcinoma of the esophagus

BACKGROUND: Esophageal carcinoma is the ninth most prevalent cancer worldwide with squamous cell carcinoma (SCCA) and adenocarcinoma accounting for the vast majority of new cases (13,900 in 2003). Cure rates in the U.S. are less than 10%, similar to lung cancer. More than 50% of patients with esopha...

Descripción completa

Detalles Bibliográficos
Autores principales: Cash, Brooks D, Johnston, Lavonne R, Johnston, Mark H
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Technical Innovations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1845148/
https://www.ncbi.nlm.nih.gov/pubmed/17367523
http://dx.doi.org/10.1186/1477-7819-5-34

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1845148/
https://www.ncbi.nlm.nih.gov/pubmed/17367523
http://dx.doi.org/10.1186/1477-7819-5-34

Ejemplares similares